The EU(7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries. - Abstract - Europe PMC
Geriatrics, Gerontology and Aging
Classes of medications identified to cause PIMs in aged lebanese... | Download Table
PIMs identified by Screening Tool of Older Persons' potentially... | Download Scientific Diagram
Pim-1 kinase as cancer drug target: An update (Review)
Serine/Threonine Protein Kinase Pim 2 (Pim 2h or Proto Oncogene Pim 2 or PIM2 or EC 2.7.11.1) - Drugs in Development, 2021
Explicit criteria as clinical tools to minimize inappropriate medication use and its consequences | Semantic Scholar
The EU(7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries | SpringerLink
Grupo Menarini Centroamérica y el Caribe - Menarini Receives FDA Orphan Drug Designation for SEL24/MEN1703, a first in class, dual PIM/FLT3 inhibitor for the Treatment of Acute Myeloid Leukemia
The updated PIM-Taiwan criteria: a list of potentially inappropriate medications in older people | Semantic Scholar
Prevalence of PIM according to drug and sex | Download Table
Details of the distribution of potentially inappropriate medications... | Download Table
Potentially Inappropriate Medications in the Elderly (09.08.2010)
Frequency of the prescription of PIMs | Download Table
JCM | Free Full-Text | Patient- and Prescriber-Related Factors Associated with Potentially Inappropriate Medications and Drug–Drug Interactions in Older Adults
Pharmacy Intervention Module (PIM)
IJMS | Free Full-Text | The Second-Generation PIM Kinase Inhibitor TP-3654 Resensitizes ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs
Types of potentially inappropriate medications (PIM) | Download Table
PIM to be used with cautions in older adults as per Beers criteria. | Download Scientific Diagram
PIM kinase inhibition: co-targeted therapeutic approaches in prostate cancer | Signal Transduction and Targeted Therapy
Comparison of FORTA, PRISCUS and EU(7)-PIM lists on identifying potentially inappropriate medication and its impact on cognitive function in multimorbid elderly German people in primary care: a multicentre observational study | BMJ
